The role of the endosomal sorting complexes required for transport (ESCRT) in tumorigenesis

Molecular Membrane Biology

Volumn 31, Issue 4, 2014, Pages 111-119

  Mattissek, Claudia ^a   Teis, David ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Endosomes; ESCRT; Tumorigenesis

Indexed keywords

CLAUDIN 1; EPIDERMAL GROWTH FACTOR RECEPTOR; ESCRT PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 PHOSPHATE; TUMOR SUSCEPTIBILITY GENE 101 PROTEIN; EGFR PROTEIN, HUMAN;

CARCINOGENESIS; CELL DIVISION; CELL FUNCTION; CELL MOTILITY; CELL VACUOLE; CYTOKINESIS; CYTOPLASM; DISEASE ASSOCIATION; DROSOPHILA MELANOGASTER; ENZYME ACTIVITY; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; LYSOSOME; MOUSE MODEL; MULTIVESICULAR BODY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; SULFOLOBUS ACIDOCALDARIUS; YEAST; ZEBRA FISH; ANIMAL; APOPTOSIS; BIOSYNTHESIS; CELL PROLIFERATION; DROSOPHILA; ENDOSOME; GENETICS; METABOLISM; MOUSE; NEOPLASM; PATHOLOGY; PHYSIOLOGY;

ANIMALS; APOPTOSIS; CARCINOGENESIS; CELL PROLIFERATION; DROSOPHILA; ENDOSOMAL SORTING COMPLEXES REQUIRED FOR TRANSPORT; ENDOSOMES; HUMANS; LYSOSOMES; MICE; NEOPLASMS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; ZEBRAFISH;

EID: 84901766763     PISSN: 09687688     EISSN: 14645203     Source Type: Journal    
DOI: 10.3109/09687688.2014.894210     Document Type: Review

References (95)

1. Agromayor M, Martin-Serrano J. 2013. Knowing when to but and run: mechanisms that control cytokinetic abscission. Trends Cell Biol 23: 433-441.
2. Babst M. 2005. A protein's final ESCRT. Traffic 6:2-9.
3. Babst M, Odorizzi G, Estepa EJ, Emr SD. 2000. Mammalian tumor susceptibility gene 101 (TSG101) and the yeast homologue, Vps23p, both function in late endosomal trafficking. Traffic 1:248-258.
4. Bache KG, Stuffers S, Malerod L, Slagsvold T, Raiborg C, Lechardeur D, et al. 2006. The ESCRT-III subunit hVps24 is required for degradation but not silencing of the epidermal growth factor receptor. Mol Biol Cell 17:2513-2523. (Pubitemid 43825490)
5. Bankaitis VA, Johnson LM, Emr SD. 1986. Isolation of yeast mutants defective in protein targeting to the vacuole. Proc Natl Acad Sci USA 83:9075-9079. (Pubitemid 17223539)
6. Bishop N, Woodman P. 2001. TSG101/mammalian Vps23 and mammalian Vps28 interact directly and are recruited to Vps4-induced endosomes. J Biol Chem 276:11735-11742.
7. Boyer B, Valles AM, Tucker GC, Delouvee A, Thiery JP. 1993. Involvement of cell motility in tumor progression. Symp Soc Experim Biol 47:183-195.
8. Brankatschk B, Wichert SP, Johnson SD, Schaad O, Rossner MJ, Gruenberg J. 2012. Regulation of the EGF transcriptional response by endocytic sorting. Sci Signal 5:ra21.
9. Brown CJ, Lain S, Verma CS, Fersht AR, Lane DP. 2009. Awakening guardian angels: drugging the p53 pathway. Nature Rev Cancer 9: 862-873.
10. Cai C, Zhang D, Lu P, Gao Y, Chang J. 2008. Expression and its significance of TSG101 in lung cancer tissue and lung cancer cell lines. Chin J Lung Cancer 11:172-177. (Pubitemid 351684804)
11. Carlton JG, Caballe A, Agromayor M, Kloc M, Martin-Serrano J. 2012. ESCRT-III governs the Aurora B-mediated abscission checkpoint through CHMP4C. Science 336:220-225.
12. Carlton JG, Martin-Serrano J. 2007. Parallels between cytokinesis and retroviral budding: a role for the ESCRT machinery. Science 316: 1908-1912. (Pubitemid 47025792)
13. Carney ME, Maxwell GL, Lancaster JM, Gumbs C, Marks J, Berchuck A, Futreal PA. 1998. Aberrant splicing of the TSG101 tumor suppressor gene in human breast and ovarian cancers. J Soc Gynecolog Investig 5:281-285. (Pubitemid 28427519)
14. Carstens MJ, Krempler A, Triplett AA, Van Lohuizen M, Wagner KU. 2004. Cell cycle arrest and cell death are controlled by p53-dependent and p53-independent mechanisms in Tsg101-deficient cells. J Biolog Chem 279:35984-35994. (Pubitemid 39100606)
15. Daniels MJ, Wang Y, Lee M, Venkitaraman AR. 2004. Abnormal cytokinesis in cells deficient in the breast cancer susceptibility protein BRCA2. Science 306:876-879. (Pubitemid 39446997)
16. Dukes JD, Fish L, Richardson JD, Blaikley E, Burns S, Caunt CJ, et al. 2011. Functional ESCRT machinery is required for constitutive recycling of claudin-1 and maintenance of polarity in vertebrate epithelial cells. Mol Biol Cell 22:3192-3205.
17. Foulkes WD, Shuen AY. 2013. In brief: BRCA1 and BRCA2. J Pathol 230:347-349.
18. Garrus JE, Von Schwedler UK, Pornillos OW, Morham SG, Zavitz KH, Wang HE, et al. 2001. Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding. Cell 107:55-65. (Pubitemid 32972037)
19. Gotzmann J, Mikula M, Eger A, Schulte-Hermann R, Foisner R, Beug H, Mikulits W. 2004. Molecular aspects of epithelial cell plasticity: implications for local tumor invasion and metastasis. Mutat Res 566: 9-20. (Pubitemid 38045586)
20. Hanson PI, Cashikar A. 2012. Multivesicular body morphogenesis. Annu Rev Cell Dev Biol 28:337-362.
21. Henne WM, Buchkovich NJ, Emr SD. 2011. The ESCRT pathway. Develop Cell 21:77-91.
22. Herz HM, Chen Z, Scherr H, Lackey M, Bolduc C, Bergmann A. 2006. Vps25 mosaics display non-autonomous cell survival and overgrowth, and autonomous apoptosis. Development 133:1871-1880. (Pubitemid 43881253)
23. Jiang Y, Ou Y, Cheng X. 2013. Role of TSG101 in cancer. Front Biosci 18:279-288.
24. Jones CB, Ott EM, Keener JM, Curtiss M, Sandrin V, Babst M. 2012. Regulation of membrane protein degradation by starvation-response pathways. Traffic 13:468-482.
25. Katzmann DJ, Babst M, Emr SD. 2001. Ubiquitin-dependent sorting into the multivesicular body pathway requires the function of a conserved endosomal protein sorting complex, ESCRT-I. Cell 106:145-155. (Pubitemid 32772626)
26. Komada M, Soriano P. 1999. Hrs, a FYVE finger protein localized to early endosomes, is implicated in vesicular traffic and required for ventral folding morphogenesis. Genes Develop 13:1475-1485. (Pubitemid 29270251)
27. Krempler A, Henry MD, Triplett AA, Wagner KU. 2002. Targeted deletion of the Tsg101 gene results in cell cycle arrest at G1/S and p53-independent cell death. J Biol Chem 277:43216-43223. (Pubitemid 35285707)
28. Lekomtsev S, Guizetti J, Pozniakovsky A, Gerlich DW, Petronczki M. 2010. Evidence that the tumor-suppressor protein BRCA2 does not regulate cytokinesis in human cells. J Cell Sci 123:1395-1400.
29. Leung KF, Dacks JB, Field MC. 2008. Evolution of the multivesicular body ESCRT machinery; retention across the eukaryotic lineage. Traffic 9:1698-1716.
30. Li J, Belogortseva N, Porter D, Park M. 2008. Chmp1A functions as a novel tumor suppressor gene in human embryonic kidney and ductal pancreatic tumor cells. Cell Cycle 7:2886-2893.
31. Li L, Cohen SN. 1996. Tsg101: a novel tumor susceptibility gene isolated by controlled homozygous functional knockout of allelic loci in mammalian cells. Cell 85:319-329. (Pubitemid 26160704)
32. Li L, Francke U, Cohen SN. 1998. Retraction. The TSG101 tumor susceptibility gene is located in chromosome 11 band p15 and is mutated in human breast cancer. Cell 93:following 660.
33. Li L, Li X, Francke U, Cohen SN. 1997. The TSG101 tumor susceptibility gene is located in chromosome 11 band p15 and is mutated in human breast cancer. Cell 88:143-154. (Pubitemid 27180338)
34. Li L, Liao J, Ruland J, Mak TW, Cohen SN. 2001. A TSG101/MDM2 regulatory loop modulates MDM2 degradation and MDM2/p53 feedback control. Proc Natl Acad Sci USA 98:1619-1624. (Pubitemid 32165548)
35. Liao Z, Thomas SN, Wan Y, Lin HH, Ann DK, Yang AJ. 2013. An internal standard-assisted synthesis and degradation proteomic approach reveals the potential linkage between Vps4B depletion and activation of fatty acid beta-oxidation in breast cancer cells. Int J Proteom 2013:291415.
36. Lin HH, Li X, Chen JL, Sun X, Cooper FN, Chen YR, et al. 2012. Identification of an AAA ATPase Vps4B-dependent pathway that modulates epidermal growth factor receptor abundance and signaling during hypoxia. Mol Cell Biol 32:1124-1138.
37. Lindas AC, Karlsson EA, Lindgren MT, Ettema TJ, Bernander R. 2008. A unique cell division machinery in the Archaea. Proc Natl Acad Sci USA 105:18942-18946.
38. Liu F, Yu Y, Jin Y, Fu S. 2010. TSG101, identified by screening a cancer cDNA library and soft agar assay, promotes cell proliferation in human lung cancer. Mol Biol Rep 37:2829-2838.
39. Liu RT, Huang CC, You HL, Chou FF, Hu CC, Chao FP, et al. 2002. Overexpression of tumor susceptibility gene TSG101 in human papillary thyroid carcinomas. Oncogene 21:4830-4837.
40. Lloyd TE, Atkinson R, Wu MN, Zhou Y, Pennetta G, Bellen HJ. 2002. Hrs regulates endosome membrane invagination and tyrosine kinase receptor signaling in Drosophila. Cell 108:261-269. (Pubitemid 34161145)
41. Lobert VH, Brech A, Pedersen NM, Wesche J, Oppelt A, Malerod L, Stenmark H. 2010. Ubiquitination of alpha 5 beta 1 integrin controls fibroblast migration through lysosomal degradation of fibronectinintegrin complexes. Develop Cell 19:148-159.
42. Lu H, Bilder D. 2005. Endocytic control of epithelial polarity and proliferation in Drosophila. Nature Cell Biol 7:1232-1239.
43. Lu P, Zhang D, Gao Y, Hu C. 2007. Expression and significance of TSG101, P21 and P300/CBP in squamous cell carcinoma and adenocarcinoma of the lung. Chin J Lung Cancer 10:197-202. (Pubitemid 47020211)
44. Ma XR, Edmund Sim UH, Pauline B, Patricia L, Rahman J. 2008. Overexpression of WNT2 and TSG101 genes in colorectal carcinoma. Trop Biomed 25:46-57.
45. Malerod L, Stuffers S, Brech A, Stenmark H. 2007. Vps22/EAP30 in ESCRT-II mediates endosomal sorting of growth factor and chemokine receptors destined for lysosomal degradation. Traffic 8: 1617-1629. (Pubitemid 47578365)
46. Martin-Serrano J, Zang T, Bieniasz PD. 2001. HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress. Nature Med 7:1313-1319. (Pubitemid 34007935)
47. Martin-Serrano J, Zang T, Bieniasz PD. 2003. Role of ESCRT-I in retroviral budding. J Virol 77:4794-4804. (Pubitemid 36402829)
48. McCullough J, Colf LA, Sundquist WI. 2013. Membrane fission reactions of the mammalian ESCRT pathway. Annu Rev Biochem 82:663-692.
49. Moberg KH, Schelble S, Burdick SK, Hariharan IK. 2005. Mutations in erupted, the Drosophila ortholog of mammalian tumor susceptibility gene 101, elicit non-cell-autonomous overgrowth. Develop Cell 9: 699-710. (Pubitemid 41555151)
50. Mochida GH, Ganesh VS, De Michelena MI, Dias H, Atabay KD, Kathrein KL, et al. 2012. CHMP1A encodes an essential regulator of BMI1-INK4A in cerebellar development. Nature Genet 44: 1260-1264.
51. Mondal G, Rowley M, Guidugli L, Wu J, Pankratz VS, Couch FJ. 2012. BRCA2 localization to the midbody by filamin A regulates cep55 signaling and completion of cytokinesis. Develop Cell 23: 137-152.
52. Morita E, Sandrin V, Chung HY, Morham SG, Gygi SP, Rodesch CK, Sundquist WI. 2007. Human ESCRT and ALIX proteins interact with proteins of the midbody and function in cytokinesis. EMBO J 26: 4215-4227. (Pubitemid 47525161)
53. Morris CR, Stanton MJ, Manthey KC, Oh KB, Wagner KU. 2012. A knockout of the Tsg101 gene leads to decreased expression of ErbB receptor tyrosine kinases and induction of autophagy prior to cell death. PLoS One 7:e34308.
54. Mosesson Y, Mills GB, Yarden Y. 2008. Derailed endocytosis: an emerging feature of cancer. Nat Rev Cancer 8:835-850.
55. Nikolova DN, Doganov N, Dimitrov R, Angelov K, Low SK, Dimova I, Toncheva D, et al. 2009. Genome-wide gene expression profiles of ovarian carcinoma: identification of molecular targets for the treatment of ovarian carcinoma. Molec Med Rep 2:365-384.
56. Odorizzi G, Babst M, Emr SD. 1998. Fab1p PtdIns(3)P 5-kinase function essential for protein sorting in the multivesicular body. Cell 95: 847-858. (Pubitemid 29014464)
57. Oh KB, Stanton MJ, West WW, Todd GL, Wagner KU. 2007. Tsg101 is upregulated in a subset of invasive human breast cancers and its targeted overexpression in transgenic mice reveals weak oncogenic properties for mammary cancer initiation. Oncogene 26:5950-5959.
58. Pharoah PD, Tsai YY, Ramus SJ, Phelan CM, Goode EL, Lawrenson K, et al. 2013. GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. Nature Genet 45:362-370, 370e1-2.
59. Qian J, Zhang XH, Yang JB, Wang JR, Zhang BC, Tang K, Li GY. 2001. Cloning and expression analysis of a novel gene, UBAP1, possibly involved in ubiquitin pathway. Acta Biochim Biophys Sinica 33: 147-152. (Pubitemid 33727655)
60. Raiborg C, Malerod L, Pedersen NM, Stenmark H. 2008. Differential functions of Hrs and ESCRT proteins in endocytic membrane trafficking. Exp Cell Res 314:801-813. (Pubitemid 351191901)
61. Raymond CK, Howald-Stevenson I, Vater CA, Stevens TH. 1992. Morphological classification of the yeast vacuolar protein sorting mutants: evidence for a prevacuolar compartment in class E vps mutants. Mol Biol Cell 3:1389-1402. (Pubitemid 23091465)
62. Rothman JH, Stevens TH. 1986. Protein sorting in yeast: mutants defective in vacuole biogenesis mislocalize vacuolar proteins into the late secretory pathway. Cell 47:1041-1051. (Pubitemid 17005076)
63. Ruland J, Sirard C, Elia A, Macpherson D, Wakeham A, Li L, et al. 2001. p53 accumulation, defective cell proliferation, and early embryonic lethality in mice lacking tsg101. Proc Natl Acad Sci USA 98:1859-1864. (Pubitemid 32165588)
64. Rusten TE, Vaccari T, Stenmark H. 2012. Shaping development with ESCRTs. Nature Cell Biol 14:38-45.
65. Sagona AP, Stenmark H. 2010. Cytokinesis and cancer. FEBS Lett 584: 2652-2661.
66. Samson RY, Obita T, Freund SM, Williams RL, Bell SD. 2008. A role for the ESCRT system in cell division in archaea. Science 322: 1710-1713.
67. Schmidt O, Teis D. 2012. The ESCRT machinery. Curr Biol 22: R116-120.
68. Scoles DR, Qin Y, Nguyen V, Gutmann DH, Pulst SM. 2005. HRS inhibits EGF receptor signaling in the RT4 rat schwannoma cell line. Biochem Biophys Res Commun 335:385-392. (Pubitemid 41140234)
69. Spitzer C, Schellmann S, Sabovljevic A, Shahriari M, Keshavaiah C, Bechtold N, et al. 2006. The Arabidopsis elch mutant reveals functions of an ESCRT component in cytokinesis. Development 133: 4679-4689. (Pubitemid 46063080)
70. Stefani F, Zhang L, Taylor S, Donovan J, Rollinson S, Doyotte A, et al. 2011. UBAP1 is a component of an endosome-specific ESCRT-I complex that is essential for MVB sorting. Curr Biol 21: 1245-1250.
71. Steiner P, Barnes DM, Harris WH, Weinberg RA. 1997. Absence of rearrangements in the tumour susceptibility gene TSG101 in human breast cancer. Nature Genet 16:332-333.
72. Théry C. 2011. Exosomes: secreted vesicles and intercellular communications. F1000 Biol Rep 3:15.
73. Thompson BJ, Mathieu J, Sung HH, Loeser E, Rorth P, Cohen SM. 2005. Tumor suppressor properties of the ESCRT-II complex component Vps25 in Drosophila. Develop Cell 9:711-720. (Pubitemid 41555152)
74. Toyoshima M, Tanaka N, Aoki J, Tanaka Y, Murata K, Kyuuma M, et al. 2007. Inhibition of tumor growth and metastasis by depletion of vesicular sorting protein Hrs: its regulatory role on E-cadherin and beta-catenin. Cancer Res 67:5162-5171. (Pubitemid 46997253)
75. Tu C, Ortega-Cava CF, Winograd P, Stanton MJ, Reddi AL, Dodge I, et al. 2010. Endosomal-sorting complexes required for transport (ESCRT) pathway-dependent endosomal traffic regulates the localization of active Src at focal adhesions. Proc Natl Acad Sci USA 107: 16107-16112.
76. Urbe S, Sachse M, Row PE, Preisinger C, Barr FA, Strous G, et al. 2003. The UIM domain of Hrs couples receptor sorting to vesicle formation. J Cell Sci 116:4169-4179. (Pubitemid 37337090)
77. Vaccari T, Bilder D. 2005. The Drosophila tumor suppressor Vps25 prevents nonautonomous overproliferation by regulating notch trafficking. Develop Cell 9:687-698. (Pubitemid 41555150)
78. Vaccari T, Rusten TE, Menut L, Nezis IP, Brech A, Stenmark H, Bilder D. 2009. Comparative analysis of ESCRT-I, ESCRT-II and ESCRT-III function in Drosophila by efficient isolation of ESCRT mutants. J Cell Sci 122:2413-2423.
79. Verplank L, Bouamr F, Lagrassa TJ, Agresta B, Kikonyogo A, Leis J, Carter CA. 2001. Tsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55(Gag). Proc Natl Acad Sci USA 98:7724-7729. (Pubitemid 32642628)
80. Von Schwedler UK, Stuchell M, Muller B, Ward DM, Chung HY, Morita E, et al. 2003. The protein network of HIV budding. Cell 114: 701-713. (Pubitemid 37203363)
81. Votteler J, Sundquist WI. 2013. Virus budding and the ESCRT pathway. Cell Host Microbe 14:232-241.
82. Wagner KU, Krempler A, Qi Y, Park K, Henry MD, Triplett AA, et al. 2003. Tsg101 is essential for cell growth, proliferation, and cell survival of embryonic and adult tissues. Mol Cell Biol 23: 150-162. (Pubitemid 36008509)
83. Walker GE, Antoniono RJ, Ross HJ, Paisley TE, Oh Y. 2006. Neuroendocrine-like differentiation of non-small cell lung carcinoma cells: regulation by cAMP and the interaction of mac25/IGFBP-rP1 and 25.1. Oncogene 25:1943-1954.
84. Wilson EM, Oh Y, Hwa V, Rosenfeld RG. 2001. Interaction of IGF-binding protein-related protein 1 with a novel protein, neuroendocrine differentiation factor, results in neuroendocrine differentiation of prostate cancer cells. J Clin Endocrinol Metabol 86:4504-4511. (Pubitemid 32848581)
85. Wittinger M, Vanhara P, El-Gazzar A, Savarese-Brenner B, Pils D, Anees M, et al. 2011. hVps37A Status affects prognosis and cetuximab sensitivity in ovarian cancer. Clin Cancer Res 17: 7816-7827.
86. Woodfield SE, Graves HK, Hernandez JA, Bergmann A. 2013. De-regulation of JNK and JAK/STAT signaling in ESCRT-II mutant tissues cooperatively contributes to neoplastic tumorigenesis. PLoS One 8:e56021.
87. Xiao B, Fan S, Zeng Z, Xiong W, Cao L, Yang Y, et al. 2006. Purification of novel UBAP1 protein and its decreased expression on nasopharyngeal carcinoma tissue microarray. Protein Expres Purificat 47:60-67.
88. Xu Z, Liang L, Wang H, Li T, Zhao M. 2003. HCRP1, a novel gene that is downregulated in hepatocellular carcinoma, encodes a growth-inhibitory protein. Biochem Biophys Res Commun 311: 1057-1066. (Pubitemid 37393426)
89. Yamada M, Ishii N, Asao H, Murata K, Kanazawa C, Sasaki H, Sugamura K. 2002. Signal-transducing adaptor molecules STAM1 and STAM2 are required for T-cell development and survival. Mol Cell Biol 22:8648-8658. (Pubitemid 35397179)
90. Young TW, Mei FC, Rosen DG, Yang G, Li N, Liu J, Cheng X. 2007a. Up-regulation of tumor susceptibility gene 101 protein in ovarian carcinomas revealed by proteomics analyses. Mol Cell Proteom 6: 294-304. (Pubitemid 46359517)
91. Young TW, Rosen DG, Mei FC, Li N, Liu J, Wang XF, Cheng X. 2007b. Up-regulation of tumor susceptibility gene 101 conveys poor prognosis through suppression of p21 expression in ovarian cancer. Clin Cancer Res 13:3848-3854. (Pubitemid 47037590)
92. Zhang Y, Song M, Cui ZS, Li CY, Xue XX, Yu M, et al. 2011. Downregulation of TSG101 by small interfering RNA inhibits the proliferation of breast cancer cells through the MAPK/ERK signal pathway. Histol Histopathol 26:87-94.
93. Zheng ZY, Cheng CM, Fu XR, Chen LY, Xu L, Terrillon S, et al. 2012. CHMP6 and Vps4A mediate the recycling of Ras to the plasma membrane to promote growth factor signaling. Oncogene 31: 4630-4638.
94. Zhu G, Gilchrist R, Borley N, Chng HW, Morgan M, Marshall JF, et al. 2004. Reduction of TSG101 protein has a negative impact on tumor cell growth. Int J Cancer 109: 541-547. (Pubitemid 38339644)
95. Zivony-Elboum Y, Westbroek W, Kfir N, Savitzki D, Shoval Y, Bloom A, et al. 2012. A founder mutation in Vps37A causes autosomal recessive complex hereditary spastic paraparesis. J Medic Genet 49: 462-472.